How Does the Inspire Sleep Apnea Implant Work?

If you struggle to use a continuous positive airway pressure (CPAP) machine, you may have heard about an implanted device commonly known by the brand name Inspire. This device is a type of therapy called hypoglossal nerve stimulation. It works by monitoring your breathing and delivering a gentle electrical pulse to the nerve that controls your tongue, moving it forward to keep your airway open while you sleep ^[1][2]. Because it requires surgery and is designed for a very specific type of airway blockage, there are strict criteria you must meet to be eligible for the implant.

How the Implant Works

Unlike CPAP, which uses pressurized air to act as a splint for your airway, hypoglossal nerve stimulation works from inside your body. The system consists of three parts placed under the skin during an outpatient surgery:

• A small breathing sensor placed near your ribs.
• A stimulation lead (wire) attached to the hypoglossal nerve (the nerve that controls your tongue) in your neck.
• A pulse generator (similar to a pacemaker) implanted in your upper chest that connects the sensor and the lead ^[1].

When you go to bed, you turn the device on using a small remote. As you fall asleep, the sensor monitors your breathing effort. When you attempt to take a breath in, the pulse generator sends a mild signal to the hypoglossal nerve ^[1][3]. This signal stimulates the muscles of your tongue and throat to move forward just enough to prevent the tissue from collapsing and blocking your airway ^[2]. You can also use the remote to pause the therapy during the night if you wake up to use the restroom or drink water.

It is important to know that the pulse generator runs on a battery that typically lasts about 10 to 11 years. When the battery runs low, you will need a minor, outpatient surgery to replace the generator unit. Modern devices are generally designed to be compatible with certain types of MRI scans, but there are specific safety rules your doctor will explain.

Why It Is Only for Obstructive Sleep Apnea

Sleep apnea generally falls into three categories: obstructive sleep apnea (OSA) (a physical blockage of the airway), central sleep apnea (CSA) (a failure of the brain to send the signal to breathe), and mixed sleep apnea (a combination of both).

The Inspire implant is approved only for obstructive sleep apnea ^[4][5]. This is because the device relies on your body’s physical effort to breathe to know when to stimulate the tongue. In central sleep apnea, your body stops making the effort to breathe, meaning the sensor would not be triggered. If your sleep study shows that a significant portion of your breathing pauses are central rather than obstructive, you will not qualify for the device ^[4].

Strict Eligibility Criteria

Because it is a surgical procedure and only works for specific anatomical issues, medical guidelines require patients to meet several strict criteria ^[1][6].

1. Moderate to Severe Obstructive Sleep Apnea

You must have a documented diagnosis of moderate-to-severe OSA ^[7]. This is measured by your Apnea-Hypopnea Index (AHI), which tracks the number of times your breathing stops or becomes very shallow per hour of sleep. Generally, you need an AHI of at least 15 to be eligible ^[7][8]. The device is also typically approved only for adults ages 18 and older.

2. Documented CPAP Intolerance

Hypoglossal nerve stimulation is considered a second-line therapy ^[9]. This means you must have tried and failed to use CPAP (or another non-invasive positive airway pressure therapy) before you can be considered ^[1][6]. “CPAP intolerance” generally means you are physically unable to tolerate the mask, cannot sleep with the machine, or the machine fails to improve your symptoms despite your best efforts ^[10].

3. Body Mass Index (BMI) Limits

Your weight plays a significant role in how well the implant works, as higher body weight can reduce the therapy’s effectiveness ^[11][12]. This has led to strict Body Mass Index (BMI) limits. Recently, the FDA expanded approval for the Inspire device to patients with a BMI up to 40. However, because insurance policies often lag behind FDA guidelines, many insurance companies still require your BMI to be under 32 to qualify for coverage.

4. Favorable Drug-Induced Sleep Endoscopy (DISE)

Before you are approved for surgery, you must undergo a brief outpatient procedure called a drug-induced sleep endoscopy (DISE) ^[13][14]. You are given a mild sedative to simulate sleep, and a doctor inserts a thin, flexible camera through your nose to observe exactly how your throat and airway collapse.

The doctor is looking to rule out a pattern called complete concentric palatal collapse ^[15][16]. This means your airway collapses in a circular pattern from all sides at once. If you have this type of collapse, the implant will not work for you, and it is considered a firm reason not to proceed with the surgery ^[4][17].

Risks and Side Effects

Like any surgery, getting the implant comes with risks, though serious adverse events during the procedure are low ^[7]. Potential surgical complications include infection at the incision site, bleeding, and nerve damage ^[18][19].

After the device is activated, some patients experience side effects like tongue soreness, mouth dryness, or discomfort when the electrical stimulation turns on. Sometimes, device issues such as technical malfunctions or the device moving out of place (migration) can require additional surgery to remove or adjust the implant ^[18][19]. Some patients may also experience treatment-emergent central sleep apnea, especially if the device is set to higher stimulation voltages ^[20][21].

Next Steps

If you meet these general criteria and are interested in learning more, your best next step is to schedule an appointment with a sleep medicine specialist or an Ear, Nose, and Throat (ENT) doctor who specializes in sleep surgery. They can review your previous sleep study, discuss whether you are a candidate, and help you navigate the process of insurance authorization and setting up a DISE evaluation.